Anti-DR5 antibody
3
(1 Review)
|
(3 Publications)
Rabbit Polyclonal DR5 antibody. Suitable for ICC, WB and reacts with Human, Rat samples. Cited in 3 publications.
View Alternative Names
CD262, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9, UNQ160/PRO186, TNFRSF10B, Tumor necrosis factor receptor superfamily member 10B, Death receptor 5, TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2
- ICC
Supplier Data
Immunocytochemistry - Anti-DR5 antibody (AB16329)
Immunocytochemistry analysis of DR5 was done on 70% confluent log phase HeLa cell. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 10 minutes, and blocked with 1% BSA for 1 hour at room temperature. The cells were labeled with ab16329 at 2 μg/mL in 0.1% BSA and incubated for 3 hours at room temperature and then labeled with Goat anti-Rabbit IgG (H+L) Superclonal™ Secondary Antibody, Alexa Fluor® 488 conjugate at a dilution of 1/2000 for 45 minutes at room temperature (Panel a : green). Nuclei (Panel b : blue) were stained with SlowFade® Gold Antifade Mountant with DAPI. F-actin (Panel c : red) was stained with Alexa Fluor® 555 Rhodamine Phalloidin at 1/300. Panel d is a merged image showing nuclear localization. Panel e is a no primary antibody control. The images were captured at 60X magnification.
- ICC
Supplier Data
Immunocytochemistry - Anti-DR5 antibody (AB16329)
Immunocytochemistry analysis of DR5 (TRAIL-R2) was performed using HCT 116 cells and HCT 116 treated with Thapsigargin (1 μM, 36 hours). The cells were fixed with 4% paraformaldehyde for 10 minutes, and blocked with 2% BSA for 1 hour at room temperature. The cells were labeled with ab16329 at 2 μg/mL in 0.1% BSA and incubated overnight at 4 degree and then labeled with Donkey anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 488 at a dilution of 1/2000 for 45 minutes at room temperature (Panel a : green) in HCT 116 treated cells. Nuclei (Panel b : blue) were stained with ProLong™ Diamond Antifade Mountant with DAPI. F-actin (Panel c : red) was stained with Rhodamine Phalloidin 1/300. Panel d represents the merged image of HCT116 treated cells, which shows higher expression for TRAIL-R2 protein showing localization in nucleus, cytoplasm and membrane. Panel e represents the merged image of untreated HCT 116 cells, that shows lower or no expression for TRAIL-R2 protein. Panel f represents control cells with no primary antibody to assess background. The images were captured at 60X magnification.
- WB
Supplier Data
Western blot - Anti-DR5 antibody (AB16329)
Detected by chemiluminescence
All lanes:
Western blot - Anti-DR5 antibody (ab16329) at 2 µg/mL
Lane 1:
A549 cell lysate at 20 µg
Lane 2:
HEL 92.1.7 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG (H+L) Superclonal™ at 1/2500 dilution
Predicted band size: 47 kDa
false
- WB
Supplier Data
Western blot - Anti-DR5 antibody (AB16329)
All lanes:
Western blot - Anti-DR5 antibody (ab16329) at 1/1000 dilution
Lane 1:
HeLa cell lysate at 25 µg
Lane 2:
PC12 cell lysate at 25 µg
Secondary
All lanes:
HRP conjugated anti-rabbit
Predicted band size: 195 kDa,47 kDa
Observed band size: 58 kDa
true
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
DR5 plays a significant role in the regulation of apoptosis particularly in cancer cells. It is a component of the TRAIL receptor complex which includes several other death receptors like DR4. This complex formation allows DR5 to mediate apoptotic signals more efficiently. By controlling apoptosis DR5 helps maintain tissue homeostasis and prevents abnormal cell proliferation.
Pathways
DR5 is an important part of the TRAIL signaling pathway and the extrinsic apoptosis pathway. It connects with proteins like FADD and Caspase-8 essential in the apoptotic signaling cascade. By interacting with these proteins DR5 drives the progression of the apoptotic signal ensuring the removal of dysfunctional cells. Such pathways are vital for restraining tumor development and progression.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Cancer management and research 12:10397-10409 PubMed33116894
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of international medical research 47:962-972 PubMed30621488
2019
Applications
Unspecified application
Species
Unspecified reactive species
Toxicologic pathology 42:1229-37 PubMed24670816
2014
Applications
Unspecified application
Species
Rat
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com